This Exemption ends on: (a) 30 April 2015; or (b) for the individual goods, when: • The goods described at paragraphs 1(i) (a)-(c) receive a marketing approval in Australia for treatment for decorporation of transuranium heavy metal radionuclides; • The goods described at paragraph 1(ii) receive a marketing approval in Australia for the treatment of plague infection; • The goods described at paragraph 1(iii) receive a marketing approval in Australia for the treatment of viral haemorrhagic fever; whichever occurs first.